Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria
NCT00199251 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2005-12-23
Summary
· To evaluate the efficacy of rupatadine 10 and 20 mg for the treatment of CIU symptoms over four-week treatment period in comparison with placebo.
Conditions
- Urticaria
Interventions
- DRUG
-
RUPATADINE
Sponsors & Collaborators
-
J. Uriach and Company
lead INDUSTRY
Principal Investigators
-
EVA ARNAIZ, PhD · J. Uriach y Compañía
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-04-30
- Completion
- 2005-06-30
More Related Trials
-
This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines
NCT03926611 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.
NCT06736340 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Efficacy and Safety of TLL-018 in CSU Participants
NCT06396026 ·Status: RECRUITING ·Phase: PHASE3
-
Study on Mastocytosis for Rupatadine Treatment
NCT01481909 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants
NCT06708520 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)
NCT01916967 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
NCT06819774 ·Status: RECRUITING ·Phase: PHASE3
-
Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
NCT05107115 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
NCT00524836 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Single Dose of LP-003 in Adolescent Subjects
NCT07148557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
NCT04426890 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
NCT02372604 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
NCT07220811 ·Status: RECRUITING ·Phase: PHASE2
-
CUTE (Chronic Urticaria Treatment Evaluation)
NCT00264303 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects
NCT00295022 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen
NCT00291642 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)
NCT00751218 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)
NCT00751166 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
NCT00619801 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
NCT00521131 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
NCT03463135 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
NCT04981717 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Stapokibart Injection in Patients With Allergic Rhinitis
NCT06525597 ·Status: RECRUITING ·Phase: PHASE2